Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 1;15(1):e2023043.
doi: 10.4084/MJHID.2023.043. eCollection 2023.

In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience

Angela Quirino  1 , Claudia Cicino  1 , Vincenzo Scaglione  2 , Nadia Marascio  1 , Francesca Serapide  2 , Giuseppe Guido Maria Scarlata  1 , Rosaria Lionello  2 , Francesca Divenuto  1 , Valentina La Gamba  2 , Grazia Pavia  1 , Alessandro Russo  2 , Carlo Torti  2 , Giovanni Matera  1 , Enrico Maria Trecarichi  2
Affiliations

In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience

Angela Quirino et al. Mediterr J Hematol Infect Dis. .
No abstract available

Keywords: Antimicrobial resistance; CRAB; Cefiderocol; Guidelines.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no conflict of Interest.

References

    1. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–655. - PMC - PubMed
    1. Reale M, Strazzulla A, Quirino A, Rizzo C, Marano V, Postorino MC, Mazzitelli M, Greco G, Pisani V, Costa C, et al. Patterns of multi-drug resistant bacteria at first culture from patients admitted to a third level University hospital in Calabria from 2011 to 2014: implications for empirical therapy and infection control. Infez Med. 2017;25:98–107. - PubMed
    1. Scaglione V, Reale M, Davoli C, Mazzitelli M, Serapide F, Lionello R, La Gamba V, Fusco P, Bruni A, Procopio D, et al. Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital. Microb Drug Resist. 2022;28:425–435. doi: 10.1089/mdr.2021.0109. - DOI - PMC - PubMed
    1. Serapide F, Quirino A, Scaglione V, Morrone HL, Longhini F, Bruni A, Garofalo E, Matera G, Marascio N, Scarlata GGM, et al. Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19? Microorganisms. 2022;10:957. doi: 10.3390/microorganisms10050957. - DOI - PMC - PubMed
    1. Hsueh SC, Lee YJ, Huang YT, Liao CH, Tsuji M, Hsueh PR. In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan. J Antimicrob Chemother. 2019;74:380–386. doi: 10.1093/jac/dky425. - DOI - PubMed